Autolus Therapeutics PLCNASDAQ:AUTL
- LAST PRICE3.9200
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots3.7000/ 1
- Ask / Lots4.5800/ 1
- Open / Previous Close0.0000 / 3.9200
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | AUTL |
|---|---|---|
| 09:32 ET | 7712 | 3.87 |
| 09:34 ET | 4037 | 3.84 |
| 09:36 ET | 1481 | 3.83 |
| 09:38 ET | 1800 | 3.83 |
| 09:39 ET | 100 | 3.82 |
| 09:41 ET | 3586 | 3.8447 |
| 09:43 ET | 1800 | 3.85 |
| 09:45 ET | 100 | 3.855 |
| 09:48 ET | 7237 | 3.87 |
| 09:50 ET | 1600 | 3.875 |
| 09:52 ET | 1208 | 3.87 |
| 09:54 ET | 3579 | 3.87 |
| 09:56 ET | 3455 | 3.87 |
| 09:57 ET | 3859 | 3.87 |
| 09:59 ET | 4574 | 3.87 |
| 10:01 ET | 4165 | 3.88 |
| 10:03 ET | 3766 | 3.87 |
| 10:06 ET | 520 | 3.87 |
| 10:08 ET | 700 | 3.87 |
| 10:10 ET | 1100 | 3.87 |
| 10:12 ET | 1310 | 3.865 |
| 10:14 ET | 1300 | 3.87 |
| 10:17 ET | 503 | 3.87 |
| 10:19 ET | 2000 | 3.895 |
| 10:21 ET | 1893 | 3.895 |
| 10:24 ET | 720 | 3.8903 |
| 10:28 ET | 109 | 3.8807 |
| 10:30 ET | 46645 | 3.885 |
| 10:32 ET | 14973 | 3.87 |
| 10:33 ET | 1100 | 3.875 |
| 10:35 ET | 3610 | 3.87 |
| 10:37 ET | 2851 | 3.875 |
| 10:39 ET | 300 | 3.875 |
| 10:42 ET | 3318 | 3.87 |
| 10:44 ET | 5866 | 3.87 |
| 10:46 ET | 17034 | 3.85 |
| 10:48 ET | 600 | 3.845 |
| 10:50 ET | 679 | 3.8475 |
| 10:51 ET | 2100 | 3.855 |
| 10:55 ET | 300 | 3.855 |
| 10:57 ET | 100 | 3.86 |
| 11:00 ET | 100 | 3.855 |
| 11:02 ET | 2800 | 3.855 |
| 11:04 ET | 200 | 3.85 |
| 11:06 ET | 3177 | 3.86 |
| 11:08 ET | 100 | 3.865 |
| 11:09 ET | 300 | 3.865 |
| 11:11 ET | 100 | 3.865 |
| 11:13 ET | 500 | 3.865 |
| 11:15 ET | 416 | 3.86 |
| 11:20 ET | 12550 | 3.865 |
| 11:22 ET | 4362 | 3.885 |
| 11:24 ET | 200 | 3.885 |
| 11:26 ET | 5559 | 3.92 |
| 11:27 ET | 300 | 3.915 |
| 11:29 ET | 7727 | 3.91 |
| 11:31 ET | 1700 | 3.92 |
| 11:33 ET | 464 | 3.925 |
| 11:36 ET | 200 | 3.925 |
| 11:38 ET | 600 | 3.92 |
| 11:40 ET | 600 | 3.92 |
| 11:42 ET | 500 | 3.92 |
| 11:45 ET | 2067 | 3.92 |
| 11:47 ET | 478 | 3.92 |
| 11:49 ET | 200 | 3.925 |
| 11:51 ET | 1000 | 3.92 |
| 11:54 ET | 1414 | 3.92 |
| 11:58 ET | 200 | 3.91 |
| 12:02 ET | 900 | 3.91 |
| 12:03 ET | 1000 | 3.9101 |
| 12:05 ET | 1300 | 3.92 |
| 12:07 ET | 1812 | 3.905 |
| 12:12 ET | 3000 | 3.915 |
| 12:14 ET | 100 | 3.915 |
| 12:16 ET | 200 | 3.915 |
| 12:18 ET | 600 | 3.92 |
| 12:20 ET | 200 | 3.91 |
| 12:21 ET | 255 | 3.915 |
| 12:23 ET | 100 | 3.91 |
| 12:25 ET | 300 | 3.91 |
| 12:34 ET | 300 | 3.91 |
| 12:38 ET | 500 | 3.91 |
| 12:41 ET | 400 | 3.905 |
| 12:43 ET | 100 | 3.905 |
| 12:48 ET | 1999 | 3.915 |
| 12:50 ET | 200 | 3.915 |
| 12:52 ET | 2250 | 3.925 |
| 12:54 ET | 200 | 3.93 |
| 12:56 ET | 1100 | 3.925 |
| 12:59 ET | 500 | 3.92 |
| 01:03 ET | 100 | 3.915 |
| 01:06 ET | 2000 | 3.9 |
| 01:08 ET | 900 | 3.9 |
| 01:10 ET | 1100 | 3.905 |
| 01:12 ET | 1400 | 3.905 |
| 01:14 ET | 100 | 3.905 |
| 01:17 ET | 100 | 3.905 |
| 01:21 ET | 1000 | 3.9 |
| 01:24 ET | 600 | 3.9 |
| 01:28 ET | 1122 | 3.895 |
| 01:30 ET | 100 | 3.895 |
| 01:32 ET | 200 | 3.89 |
| 01:35 ET | 100 | 3.89 |
| 01:44 ET | 100 | 3.885 |
| 01:46 ET | 2205 | 3.9 |
| 01:48 ET | 652 | 3.8999 |
| 01:50 ET | 100 | 3.89 |
| 01:51 ET | 1566 | 3.9 |
| 01:53 ET | 100 | 3.895 |
| 02:02 ET | 100 | 3.895 |
| 02:04 ET | 4956 | 3.895 |
| 02:06 ET | 2003 | 3.895 |
| 02:09 ET | 500 | 3.895 |
| 02:11 ET | 100 | 3.895 |
| 02:13 ET | 526 | 3.89 |
| 02:15 ET | 1161 | 3.895 |
| 02:18 ET | 200 | 3.895 |
| 02:20 ET | 1200 | 3.895 |
| 02:22 ET | 100 | 3.89 |
| 02:24 ET | 1715 | 3.9 |
| 02:26 ET | 2089 | 3.89 |
| 02:27 ET | 2500 | 3.89 |
| 02:29 ET | 3285 | 3.88 |
| 02:31 ET | 1482 | 3.885 |
| 02:33 ET | 100 | 3.88 |
| 02:36 ET | 700 | 3.885 |
| 02:38 ET | 1006 | 3.87 |
| 02:40 ET | 100 | 3.87 |
| 02:42 ET | 7968 | 3.89 |
| 02:44 ET | 400 | 3.88 |
| 02:45 ET | 1200 | 3.885 |
| 02:47 ET | 200 | 3.89 |
| 02:49 ET | 100 | 3.88 |
| 02:51 ET | 200 | 3.88 |
| 02:54 ET | 600 | 3.885 |
| 02:56 ET | 500 | 3.885 |
| 02:58 ET | 500 | 3.885 |
| 03:00 ET | 600 | 3.89 |
| 03:02 ET | 2848 | 3.88 |
| 03:03 ET | 600 | 3.88 |
| 03:05 ET | 100 | 3.88 |
| 03:07 ET | 100 | 3.885 |
| 03:09 ET | 1009 | 3.885 |
| 03:12 ET | 3158 | 3.9 |
| 03:14 ET | 16370 | 3.915 |
| 03:16 ET | 1204 | 3.905 |
| 03:18 ET | 700 | 3.9 |
| 03:20 ET | 1500 | 3.905 |
| 03:23 ET | 300 | 3.9 |
| 03:25 ET | 200 | 3.9 |
| 03:27 ET | 300 | 3.9 |
| 03:30 ET | 1400 | 3.91 |
| 03:32 ET | 1216 | 3.905 |
| 03:34 ET | 300 | 3.9 |
| 03:36 ET | 3842 | 3.915 |
| 03:38 ET | 5263 | 3.93 |
| 03:39 ET | 3296 | 3.93 |
| 03:41 ET | 500 | 3.92 |
| 03:43 ET | 908 | 3.92 |
| 03:45 ET | 829 | 3.92 |
| 03:48 ET | 9025 | 3.92 |
| 03:50 ET | 2500 | 3.91 |
| 03:52 ET | 2400 | 3.905 |
| 03:54 ET | 6377 | 3.9 |
| 03:56 ET | 46303 | 3.915 |
| 03:57 ET | 18719 | 3.915 |
| 03:59 ET | 60798 | 3.92 |
May 17, 2024
DJ Autolus Therapeutics Price Target Maintained With a $9.00/Share by Needham, from 1:52PM ET on Friday May 17, 2024 by Dow Jones
1:52PM ET on Friday May 17, 2024 by Dow Jones*DJ Autolus Therapeutics 1Q Loss/Shr 24c >AUTL, from 7:00AM ET on Friday May 17, 2024 by Dow Jones
7:00AM ET on Friday May 17, 2024 by Dow JonesAutolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates, from 7:00AM ET on Friday May 17, 2024 by Dow Jones
7:00AM ET on Friday May 17, 2024 by Dow Jones
May 14, 2024
Autolus Therapeutics to Present Three Clinical Data Updates on obecabtagene autoleucel (obe-cel) in relapsed/refractory (r/r) B-Cell acute lymphoblastic leukemia (ALL) patients at the 2024 European Hematology Association (EHA) Congress, from 10:00AM ET on Tuesday May 14, 2024 by Dow Jones
10:00AM ET on Tuesday May 14, 2024 by Dow Jones
May 13, 2024
*DJ Autolus Therapeutics Announces Delay to Its 1Q 2024 Earnings Release and Conference Call, from 7:01AM ET on Monday May 13, 2024 by Dow Jones
7:01AM ET on Monday May 13, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Autolus Therapeutics PLC | 1.0B | -3.3x | --- |
Cassava Sciences Inc | 1.0B | -18.6x | --- |
Verona Pharma PLC | 976.2M | -15.2x | --- |
Perspective Therapeutics Inc | 957.6M | -9.2x | --- |
Enliven Therapeutics Inc | 1.1B | -12.4x | --- |
Centessa Pharmaceuticals PLC | 934.9M | -5.8x | --- |
Company Information
Autolus Therapeutics plc is a United Kingdom-based clinical-stage biopharmaceutical company developing programmed T cell therapies for the treatment of cancer and autoimmune diseases. It is focused on chimeric antigen receptor (CAR)-T cell therapy. Using a suite of proprietary and modular T cell programming technologies, it is engineering targeted, controlled and highly active T cell therapy product candidates that are designed to recognize target cells, break down their defense mechanisms and eliminate these cells. It has a pipeline of product candidates in development for the treatment of hematological malignancies, solid tumors and autoimmune diseases. Its products pipeline includes obe-cel (FELIX), obe-cel (ALLCAR19), obe-cel (CAROUSEL), AUTO1/22 (CARPALL), AUTO4 (LibrA T1), AUTO6 (MAGNETO), AUTO5, AUTO8 (MCARTY) and AUTO9. AUTO4 and AUTO5 are two programmed T cell therapies for the treatment of peripheral T-cell lymphoma targeting T Cell Receptor Beta Constant (TRBC) 1 and TRBC 2.
Contact Information
- Headquarters
- The Mediaworks, 191 Wood LaneLONDON, United Kingdom W12 7FP
- Phone
- 203-829-6230
- Fax
- ---
Executives
- Chairman of the Board
- Michael Bonney
- Chief Executive Officer, Executive Director
- Christian Itin
- Founder, Senior Vice President, Chief Scientific Officer
- Martin Pule
- Chief Financial Officer, Senior Vice President
- Lucinda Crabtree
- Chief Operating Officer, Senior Vice President
- Christopher Vann
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.0B |
|---|---|
Revenue (TTM) | $10.5M |
Shares Outstanding | 266.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.00 |
EPS | $-1.21 |
Book Value | --- |
P/E Ratio | -3.3x |
Price/Sales (TTM) | 99.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,670.52% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
